Bio-Path Holdings Files 8-K
Ticker: BPTH · Form: 8-K · Filed: Jul 11, 2024 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, financials
Related Tickers: BPTH
TL;DR
BPTH filed an 8-K on 7/11 for a 7/8 event, likely containing financial updates.
AI Summary
Bio-Path Holdings, Inc. filed an 8-K on July 11, 2024, reporting an event that occurred on July 8, 2024. The filing indicates "Other Events" and includes "Financial Statements and Exhibits." No specific financial details or material events are detailed in the provided text, beyond the filing itself.
Why It Matters
This filing signifies that Bio-Path Holdings, Inc. has made a regulatory submission to the SEC, which may contain important updates or disclosures for investors.
Risk Assessment
Risk Level: low — The filing itself is a routine regulatory disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Registrant
- 0001558370-24-009750 (filing_id) — Accession Number
- July 8, 2024 (date) — Earliest event date
- July 11, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 77401 (zip_code) — Business address zip code
FAQ
What specific event occurred on July 8, 2024, that prompted this 8-K filing?
The provided text does not specify the exact nature of the 'Other Events' or the details of the 'Financial Statements and Exhibits' that occurred on July 8, 2024.
What is the primary business of Bio-Path Holdings, Inc.?
Bio-Path Holdings, Inc. is in the 'PHARMACEUTICAL PREPARATIONS' industry, SIC code 2834.
When was Bio-Path Holdings, Inc. incorporated?
The company was incorporated in Delaware.
What is the SEC file number for Bio-Path Holdings, Inc.?
The SEC file number for Bio-Path Holdings, Inc. is 001-36333.
What is the principal executive office address for Bio-Path Holdings, Inc.?
The address of the principal executive offices is 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401.
Filing Stats: 428 words · 2 min read · ~1 pages · Grade level 10.4 · Accepted 2024-07-11 08:38:40
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M
Filing Documents
- bpth-20240708x8k.htm (8-K) — 38KB
- bpth-20240708xex99d1.htm (EX-99.1) — 28KB
- bpth-20240708xex99d1001.jpg (GRAPHIC) — 11KB
- 0001558370-24-009750.txt ( ) — 206KB
- bpth-20240708.xsd (EX-101.SCH) — 3KB
- bpth-20240708_lab.xml (EX-101.LAB) — 16KB
- bpth-20240708_pre.xml (EX-101.PRE) — 10KB
- bpth-20240708x8k_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On July 8, 2024, Bio-Path Holdings, Inc. (the "Company") issued a press release titled, "Bio-Path Holdings Provides Clinical Update and Expansion Plans." A copy of such press release is attached hereto as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press release dated July 8, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: July 10, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer